VETO.PA • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold VETO.PA in your mock portfolio yet.
With EPS of €5.10 and a PE ratio of 16.24, Vetoquinol SA appears reasonably valued relative to typical mid-cap pharma/animal health peers, suggesting neither clear undervaluation nor overvaluation based solely on earnings. The figures imply the company is solidly profitable, but without explicit revenue and margin trend data, it is difficult to argue for a strong re‑rating case purely on fundamentals.
The stock has risen 16.6% over the last month and trades above its 200‑day moving average, indicating a positive medium‑term trend. However, an RSI of 34.67 is close to oversold territory, suggesting recent selling pressure or consolidation after the run‑up, which tempers a strongly bullish technical view.
Alternative data for Vetoquinol SA is mostly flat, with web traffic and app downloads showing 0.0% month‑over‑month growth, suggesting stable but not accelerating digital engagement. The notable positive is a 36.4% increase in job openings, which can indicate investment in growth or new initiatives, while social media audiences are small and largely stagnant, limiting their positive signal strength.
Overall, Vetoquinol SA presents as a reasonably valued, profitable company with a positive medium‑term price trend but mixed short‑term technicals and largely flat alternative data signals. The combination of a moderate PE, solid EPS, price above the 200‑day moving average, and limited evidence of accelerating demand or engagement supports a neutral outlook rather than a distinctly bullish or bearish stance.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: